Senores Pharmaceuticals Limited has informed the Exchange about Link of Recording
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Senores Pharmaceuticals has informed the stock exchanges that the audio recording of its earnings conference call held on May 16, 2025 is now available on the company's website. The call discussed the audited financial results for the quarter and financial year ended March 31, 2025. It was attended by Chairman Sanjay Majmudar, Managing Director Swapnil Shah, and Whole Time Director & CFO Deval Shah. The company clarified that no unpublished price-sensitive information was shared during the call. This is a routine compliance filing under SEBI's listing regulations, with no new financial details disclosed in the letter itself.
No direct impact on stock price or shareholders — this is a standard regulatory disclosure. Investors who want management commentary on FY25 results can listen to the recording on the company's investor page.